Wenda Brennan, V.P., Global Pharmacovigilance, UBC
Wenda Brennan discusses important areas in adverse event reporting, and trends in pharmacovigilance.
For more information please visit www.ubc.com/.
Andrew Schachter, CEO and Founder, Axiom Real-Time Metrics
Marc Hoffman, Chief Medical Officer, Celerion
Steve Clemons, Founder, VP of Clinical Operations, Vitalink Research
Tanya du Plessis, Vice President, Data Strategies and Solutions, Bioforum
MaryAnne Rizk, Ph.D., Senior Vice President, Digital R&D Strategy, IQVIA
Joel Selzer, Co-Founder and CEO, ArcheMedX
Eleanore Doyle, Executive Vice President, FSP 360, Syneos Health
Joe Ehrline, Vice President of Sales, Saama
Bruce Palsulich, Global VP of Product Strategy, Oracle
Josh Rose, VP, Strategic Planning, IQVIA
Donald A. Deieso, Ph.D., Executive Chairman & CEO, WCG
Mary Elizabeth Williams, Journalist and Author, "A Series of Catastrophes & Miracles: A True Story of Love, Science, and Cancer
Wenda Brennan, V.P., Global Pharmacovigilance, UBC
Cat Hall, VP Product Strategy, endpoint
Raj Induri, CEO, eClinical Solutions
Karin Beckstrom, Senior Product Manager, ERT
Mike Nolte, CEO, Signant Health
Evgenia Mikhalchuk, Director, Business Development & Marketing, Flex Databases
Yvonne Lungershausen, CEO, Avance Clinical
Jason Casarella, Executive V.P., Business Development & Marketing, Advanced Clinical
Larissa Comis, Product Lead, Shared Investigator Platform, Cognizant
Michelle Longmire, M.D., CEO, Medable
